The technology sector is cheap, trading at only about, roughly 13 times forward estimates. This is a significant discount to the sector's 15-year forward and 20-year trailing averages of 23 and 26, respectively, observes Stephen Leeb in The Cash Cow.
Meanwhile, the fundamental picture for the technology sector looks very promising. The improving economic picture is likely to accelerate capital spending in this sector, something that has been sorely needed since the crisis.
Corporate investment in technology, as a percentage of GDP, has fallen to a nearly 15-year low, and the average age of tech equipment at companies is particularly high. As the economy improves and corporate leaders conclusively exhale, this will undoubtedly change.
Meanwhile, the industry is lean, margins are strong, pricing pressure has largely abated, and tech companies are financially sound, precisely when a new capital spending upcycle is about to begin.
The fourth quarter has historically been good for tech stocks and equities in general. The S&P 500 (SPX) has averaged a 4.26% gain since 1980, with all ten sectors also averaging positive returns over that same time span.
Hot Telecom Companies To Watch In Right Now: ANI Pharmaceuticals Inc (ANIP)
ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173, 00 square feet, the Company manufactures oral solid dose products, as well as liquids and topicals, including narcotics. Its other products include The Food and Drug Administration (FDA) approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. In December 2013, the Company acquired 31 generic drug products from Teva Pharmaceuticals, which includes 20 solid-oral immediate release products, four extended release products and seven liquid products.
The Company performs contract manufacturing for other pharmaceutical companies. It has launched three products and has 11 products in development. The Company�� targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities.
Advisors' Opinion:- [By Ben Levisohn]
ANI Pharmaceuticals (ANIP) has climbed 8.9% to $18.80 after it said it would buy 31 generic drugs from Teva Pharmaceuticals (TEVA). Teva’s shares are little changed in pre-open trading.
- [By Lisa Levin]
ANI Pharmaceuticals (NASDAQ: ANIP) shares climbed 9.42% to $20.79. The volume of ANI Pharmaceuticals shares traded was 651% higher than normal. ANI Pharmaceuticals shares have jumped 121.45% over the past 52 weeks, while the S&P 500 index has surged 25.37% in the same period.
- [By Monica Gerson]
ANI Pharmaceuticals (NASDAQ: ANIP) reported that it has bought 31 generic drug products from Teva Pharmaceuticals (NYSE: TEVA) for $12.5 million in cash and a percentage of future gross profits. ANI Pharmaceuticals shares surged 5.14% to $18.00 in the after-hours trading session.
Top 5 Promising Companies For 2015: Bunge Limited(BG)
Bunge Limited, through its subsidiaries, engages in the agriculture and food businesses worldwide. Its Agribusiness segment is involved in purchasing, storing, transporting, processing, and selling agricultural commodities and commodity products, such as oilseeds and grains, primarily comprising soybeans, rapeseed or canola, sunflower seed, wheat, and corn. This segment serves animal feed manufacturers, wheat and corn millers, third party edible oil processing companies, and other oilseed processors, as well as livestock, poultry, and aquaculture producers. The company?s Sugar and Bioenergy segment produces and sells sugar and ethanol; generates electricity from burning sugarcane bagasse; and trades and merchandises sugar. As of December 31, 2011, this segment had a total installed capacity of approximately 144 megawatts; and sugarcane plantations of approximately 183,000 hectares under cultivation. Its Edible Oil Products segment offers packaged vegetable, including pack aged and bulk oils, shortenings, margarines, mayonnaise, and other products to baked goods companies, snack food producers, restaurant chains, foodservice distributors, and other food manufacturers. The company?s Milling Products segment produces and sells various wheat flours and bakery mixes; corn-based products; corn milling products primarily comprising dry milled corn meals, flours, and grits, as well as soy-fortified corn meal and corn-soy blend; and packaged milled rice. This segment serves industrial, bakery, and foodservice companies; and companies in food processing sector. Its Fertilizer segment produces, blends, and distributes nitrogen, phosphate, and potash formulations used for the cultivation of soybeans, corn, sugarcane, cotton, wheat, and coffee. This segment also produces single super phosphate; and ammonia, urea, and liquid fertilizers for the agriculture industry. Bunge Limited was founded in 1818 and is headquartered in White Plains, New York.
Advisors' Opinion:- [By Jonas Elmerraji]
After a slow start last year, Bunge (BG) kicked it into high gear in the last six months, catching up with the S&P's performance by year-end. But if you missed the upside in this $12 billion agribusiness, never fear. The technicals indicate that Bunge has greener pastures ahead.
That's because Bunge is currently forming an ascending triangle pattern, a bullish setup formed by horizontal resistance to the upside at $83 and uptrending support below shares. Basically, as Bunge bounces in between those two technical levels, it's getting squeezed closer and closer to a breakout above resistance. When that breakout above $83 happens, we've got our buy signal.
The 50-day moving average has been acting as a solid proxy for support all the way up Bunge's rally. That makes it a logical level to keep a protective stop if you decide to be a buyer.
Top 5 Promising Companies For 2015: Energy Transfer Equity L.P. (ETE)
Energy Transfer Equity, L.P., through its direct and indirect investments in the limited partner and general partner interests in Energy Transfer Partners, L.P., engages in midstream, intrastate, and interstate transportation of natural gas, as well as in storage of natural gas in the United States. The company?s Intrastate Transportation and Storage segment engages in the ownership and operation of natural gas transportation pipelines and natural gas storage facilities. As of December 31, 2009, it owned and operated approximately 7,800 miles of natural gas transportation pipelines and 3 natural gas storage facilities. This segment sells natural gas to electric utilities, independent power plants, local distribution companies, industrial end-users, and other marketing companies on the Houston pipeline system. Its Interstate Transportation segment involves owns and operates interstate natural gas pipeline. It owned and operates approximately 2,700 miles of interstate natura l gas pipeline with an additional 180 miles under construction. The company?s Midstream segment engages in the ownership and operation of in service natural gas gathering pipelines, natural gas processing plants, natural gas treating facilities, and natural gas conditioning facilities. This segment owned and operated approximately 7,000 miles of in service natural gas gathering pipelines, 3 natural gas processing plants, 11 natural gas treating facilities, and 11 natural gas conditioning facilities. Its Retail Propane segment operates a retail distribution network consisting of approximately 440 customer service locations in approximately 40 states. The company was formerly known as La Grange Energy, L.P. Energy Transfer Equity, L.P. was founded in 2002 and is based in Dallas, Texas.
Advisors' Opinion:- [By WilliamBriat]
Investors interested in oil and gas pipeline stocks can start researching any number of energy infrastructure companies, including Atlas Energy, L.P. (NYSE: ATLS), Energy Transfer Equity, L.P. (NYSE: ETE), and Targa Resources Partners LP (NYSE: NGLS). - [By Roberto Pedone]
Energy Transfer Equity (ETE) owns and operates natural gas gathering systems, natural gas intrastate pipeline systems and gas processing plants. This stock closed up 1.8% at $66.21 in Wednesday's trading session.
Wednesday's Volume: 4.58 million
Three-Month Average Volume: 1.28 million
Volume % Change: 321%From a technical perspective, ETE spiked higher here right off some near-term support at $63.90 with heavy upside volume. This move pushed shares of ETE into new 52-week high territory, since the stock took out some resistance at $66.97. At last check, ETE hit an intraday high of $67.90 with volume that was substantially above its three-month average action of 1.28 million shares.
Traders should now look for long-biased trades in ETE as long as it's trending above support at $63.90 or above more support at $62 and then once it sustains a move or close above its new 52-week high at $67.90 with volume that's near or above 1.28 million shares. If we get that move soon, then ETE will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $70 to $75.
- [By Igor Greenwald]
One upshot was our new recommendation of Energy Transfer Equity (ETE) as a general partner poised to capitalize on lucrative IDR streams from several subsidiary partnerships.
- [By Robert Rapier]
There are at least three areas of opportunity for MLP investors resulting from this surge in US gas production. The first, and safest avenue of profit is in partnerships that are building out natural gas infrastructure to connect major gas-producing areas like the Marcellus Shale to major population centers, or to terminals that are being built to export liquefied natural gas (LNG). The list of partnerships involved in transporting natural gas is long, but includes such names as�Energy Transfer Equity�(NYSE: ETE),�Enterprise Products Partners�(NYSE: EPD),�Kinder Morgan Energy Partners�(NYSE: KMP), and�Boardwalk Pipeline Partners�(NYSE: BWP). These partnerships tend to yield in the 3-6% range, and for the most part have relatively stable distributions (BWP being a notable recent exception with a drastic distribution cut earlier this year.)
Top 5 Promising Companies For 2015: Idenix Pharmaceuticals Inc.(IDIX)
Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and Europe. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV). The company?s HCV discovery program focuses on various classes of drugs, including nucleoside/nucleotide polymerase inhibitors, protease inhibitors, non-nucleoside polymerase inhibitors, and NS5A inhibitors. It develops products and drug candidates for the treatment of patients with hepatitis B virus (HBV), human immunodeficiency virus (HIV) type-1, and acquired immune deficiency syndrome (AIDS). The company principally has a collaboration agreement with Novartis Pharma AG for the development and commercialization of telbivudine, a drug for the treatment of HBV under the Tyzeka/Sebivo names. Idenix Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By John Udovich]
The latest biotech news or news surrounding small cap biotech stocks like Idenix Pharmaceuticals Inc (NASDAQ: IDIX), Dendreon Corporation (NASDAQ: DNDN) and TNI BioTech, Inc (OTCMKTS: TNIB) includes a merger, a CEO resignation and a steady stream of IPO filings:
No comments:
Post a Comment